Henry Schein has appointed Bradley Sheares, Ph.D., to its board of directors.
Sheares most recently served as CEO of Reliant Pharmaceuticals. Prior to joining Reliant, he served as president of U.S. Human Health at Merck & Co. from March 2001 until July 2006.
"Clearly the medical landscape in the U.S. and around the world is quickly changing, with healthcare focusing more closely on disease prevention and wellness," said Stanley Bergman, chairman and CEO of Henry Schein. "Sheares' insights into these emerging developments will figure prominently as we position our company to take full advantage of new market opportunities and support our customers in the efficient and effective delivery of care to patients."
Copyright © 2010 DrBicuspid.com
.hpp4JFpXkV.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
